Abstract:Abstract Membrane transporters play a fundamental role in the tissue distribution of endogenous compounds and xenobiotics and are major determinants of efficacy and side effects profiles. Polymorphisms within these drug transporters result in inter-individual variation in drug response, with some patients not responding to the recommended dosage of drug whereas others experience catastrophic side effects. For example, variants within the major hepatic Human organic cation transporter OCT1 (SLC22A1) can change endogenous organic cations and many prescription drug levels. To understand how variants mechanistically impact drug uptake, we systematically study how all known and possible single missense and single amino acid deletion variants impact expression and substrate uptake of OCT1. We find that human variants primarily disrupt function via folding rather than substrate uptake. Our study revealed that the major determinants of folding reside in the first 300 amino acids, including the first 6 transmembrane domains and the extracellular domain (ECD) with a stabilizing and highly conserved stabilizing helical motif making key interactions between the ECD and transmembrane domains. Using the functional data combined with computational approaches, we determine and validate a structure-function model of OCT1s conformational ensemble without experimental structures. Using this model and molecular dynamic simulations of key mutants, we determine biophysical mechanisms for how specific human variants alter transport phenotypes. We identify differences in frequencies of reduced function alleles across populations with East Asians vs European populations having the lowest and highest frequency of reduced function variants, respectively. Mining human population databases reveals that reduced function alleles of OCT1 identified in this study associate significantly with high LDL cholesterol levels. Our general approach broadly applied could transform the landscape of precision medicine by producing a mechanistic basis for understanding the effects of human mutations on disease and drug response.

Development of the Genetic Polymorphism Study on Organic Cation Transporters

Organic Anion Transporters and Their Implications in Pharmacotherapy

Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination

Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced in vitro testing

Role of organic cation transporters in drug–drug interaction

Research Advances in Organic Anion Transporter

Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease

Regulation of renal organic cation transporters

The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions

The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics

Structural basis of promiscuous substrate transport by Organic Cation Transporter 1

Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking

Structural insights into human organic cation transporter 1 transport and inhibition

Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence Motifs

Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer.

Organic anion transporter (Slc22a) family members as mediators of toxicity

Molecular pharmacology of renal organic anion transporters

Organic cation transporters: physiology, toxicology and special focus on ethidium as a novel substrate

Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2

Xenobiotic transporters: ascribing function from gene knockout and mutation studies.